New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
August 5, 2014
08:12 EDTPINC, HSPPremier acquires TheraDoc from Hospira for $117M
Premier (PINC) has reached a definitive agreement to acquire TheraDoc, a market leading provider of clinical surveillance software, for $117M in cash, subject to potential purchase price adjustments regarding TheraDoc's actual working capital, cash and indebtedness at closing. The transaction is expected to close in Premier's 1Q15 ending September 30. TheraDoc is a wholly-owned subsidiary of Hospira (HSP). Premier's board unanimously approved the transaction, and applicable antitrust approvals have already been obtained. Based on the trailing twelve months operating earnings provided by TheraDoc, the $117M represents a purchase price multiple in the 10-11 times range. Premier expects the acquisition to be accretive to earnings in the first year following the transaction's completion.
News For PINC;HSP From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
May 20, 2015
09:52 EDTHSPAlliance for Health Reform holds a webcast on biosimilars
"Biosimilars in the U.S.: Current & Emerging Issues" provides essential background on the U.S. and international markets for reference biologics and biosimilars, outline current policy and regulatory issues, and describe implications for the future. Speakers include Chief Scientific Officer Ramachandra from Hospira, Executive Director Eich from Amgen on the briefing being held on May 20 at 12 pm. Webcast Link
May 14, 2015
12:29 EDTHSPPfizer receives 'second request' from FTC regarding potential Hospira merger
Subscribe for More Information
May 13, 2015
19:17 EDTHSPHospira and FDA detect security vulnerabilities in infusion pumps
Subscribe for More Information
13:43 EDTHSPHospira shareholders approve merger with Pfizer
Hospira (HSP) announced that Hospira shareholders voted in favor of the proposal to adopt the merger agreement with Pfizer (PFE) at a special meeting of stockholders held May 13 in Denver, Colorado. On February 5, Hospira and Pfizer announced they had entered into a merger agreement under which Pfizer will acquire Hospira for $90 per share in cash for a total enterprise value of approximately $17B. The merger is subject to customary closing conditions, one of which was approval of the merger by Hospira's shareholders. Additional closing conditions to be met include obtaining regulatory approvals in several jurisdictions. Hospira and Pfizer continue to expect the merger to close in the second half of 2015.
May 11, 2015
16:21 EDTPINCPremier backs FY15 adjusted EPS $1.40-$1.44, consensus $1.42
Subscribe for More Information
16:21 EDTPINCPremier raises FY15 revenue view to $988M-$1.008B from $974M-$1B
Subscribe for More Information
16:18 EDTPINCPremier raises FY15 adjusted EBITDA view to $384M-$392M from $382M-$390M
Subscribe for More Information
16:17 EDTPINCPremier raises FY15 outlook
16:16 EDTPINCPremier reports Q3 adjusted EPS 38c, consensus 36c
Subscribe for More Information
15:00 EDTPINCNotable companies reporting after market close
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use